Menu

Vistagen Therapeutics, Inc. VTGN

Full chart Compare
Set alert

Price alert · VTGN

All alert types
0.16 USD 0.00 (-0.85%)

At closeNov 6, 2026, 6:57 PM EST

0.16 0.00 0.00%

After hours · Nov 6, 6:57 PM ET

0.1638 Day range 0.1769
0.1638 52-week range 4.90
YTD
-75.18%
1 year
-95.93%

Revenue & Expenses

Other Income → Expenses: $2.45MExpenses → Selling, General & Admin: $18.42MExpenses → Research & Development: $54.97MExpenses → Income Tax: $7.00KGross Profit → Expenses: $1.27MRevenue → Gross Profit: $1.27MNet Loss → Expenses: $69.69MOther Income$2.45MGross Profit$1.27MNet Loss$69.69MExpenses$73.40MSelling, General & Admin$18.42MResearch & Development$54.97MIncome Tax$7.00KRevenue$1.27M

Latest period ending Mar 31, 2026 · select a line to chart its full history

Annual income statement

VTGN annual income statement
Fiscal yearFY 2026 Mar 31, 2026FY 2025 Mar 31, 2025FY 2024 Mar 31, 2024FY 2023 Mar 31, 2023FY 2022 Mar 31, 2022
1.27M486.00K1.06M-227.00K1.11M
1.27M486.00K1.06M-227.00K1.11M
1.27M486.00K1.06M-227.00K1.11M
73.39M56.46M34.09M59.04M48.89M
54.97M39.38M20.02M44.38M35.41M
18.42M17.08M14.06M14.66M13.48M
-72.13M-55.97M-33.02M-59.27M-47.78M
7.00K7.00K4.00K6.00K3.40K
-69.69M-51.42M-29.36M-59.25M-47.76M
-69.69M-51.42M-29.36M-59.25M-48.71M
-69.69M-51.42M-29.36M-59.25M-48.71M
-69.69M-51.42M-29.36M-59.25M-47.76M
-1.83-1.67-1.52-8.51-7.38
-1.83-1.67-1.52-8.51-7.38
-1.83-1.67-1.52-8.51-7.38
-69.68M-51.41M-29.36M-59.24M-47.76M
-69.68M-51.41M-29.36M-59.24M-47.76M
38.07M30.88M19.35M6.96M6.60M
38.07M30.88M19.35M6.96M6.60M